TG Therapeutics Inc (TGTX)
Return on assets (ROA)
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 12,672 | -198,335 | -348,101 | -279,381 | -172,870 |
| Total assets | US$ in thousands | 329,587 | 193,572 | 379,629 | 625,642 | 163,014 |
| ROA | 3.84% | -102.46% | -91.70% | -44.66% | -106.05% |
December 31, 2023 calculation
ROA = Net income ÷ Total assets
= $12,672K ÷ $329,587K
= 3.84%
TG Therapeutics Inc's return on assets (ROA) has shown significant fluctuations over the past five years. In 2019 and 2022, the company reported negative ROA figures, indicating that the company incurred losses relative to its assets in those years. This negative trend suggests potential inefficiencies, poor investment decisions, or operational challenges that impacted the company's ability to generate profits from its assets.
However, in more recent years such as 2020, 2021, and 2023, the company managed to improve its ROA performance, with positive figures ranging from -44.66% to 3.84%. The positive ROA values suggest that TG Therapeutics Inc has been more effective in utilizing its assets to generate profits in these years, potentially indicating better operational efficiencies, stronger financial management, or successful strategic decisions.
Overall, the fluctuating trends in TG Therapeutics Inc's ROA highlight the company's varying financial performance and underscore the importance of implementing measures to consistently improve asset utilization and profitability in the long term.
Peer comparison
Dec 31, 2023